Levosimendan protects against doxorubicin induced acute cardiotoxicity by regulation of oxidative stress and by activation of antiapoptotic mechanisms - Efentakis, P; Varela, A.; Sigala, F; Kostomitsopoulos, N.; Tenta, R; Gioti, K; Parissis, J; Farmakis, D.; Iliodromitis, E.K.; Papapetropoulos, A.; others (EUROPEAN HEART JOURNAL, 2016)